Dringende oproep Testbiotech

Dringende oproep van Testbiotech. De EU wil de nieuwe gentechnieken zoals Crispr/Cas niet onder de huidige gentech EU wetgeving laten vallen. Zo kunnen nieuwe technieken er voor zorgen dat we niet meer kunnen kiezen uit conventionele – of bio landbouwproducten.

Calyxt gene-edited soybean flops in the US

GMWatch: “Gene editing has been hyped as a way to bring products with attractive traits to market much more speedily. But so far very few products have emerged from the gene editing pipe line and those that have don’t seem to tally with the industry narrative.
 
Calyxt’s gene-edited soybean, for instance, has suffered poor farmer take-up, according to an article in the US-based investment magazine Seeking Alpha, reporting in December 2020.
MORE

Calyxt gene-edited (een omstreden nieuwe gentechniek) sojabonen is een flop in de USA.

We zijn allen proefkonijnen.

Uit 2001

Omdat een aantal vaccins tegen Corona onder gentherapie vallen, zou met dit bericht van I-sIs org nog eens goed moeten lezen…

Fragment: Gene therapy clinical trials ground to a halt amid scandalous reports of deaths
and conflicts of interest [2]

2001: Last year in the US, gene therapy clinical trials ground to a halt amid scandalous
reports of deaths and conflicts of interest [2]. The US National Institutes of Health (NIH) set
up a special telephone hot line for victims that counted 652 cases of serious adverse
events along with six unexplained deaths. Effects included high fevers, infections and
severe changes in blood pressure, all of which went previously unreported to the NIH
Recombinant DNA Advisory Committee (RAC).

David Baltimore, Nobel laureate and president of Caltech, a gene therapy based biotech
company, said ” I disagree we’ve had any benefit from gene therapy trials so far, many of
us are now asking, what the hell are we doing putting these things into people?”

  1. Julie Grisham, Inquiry in gene therapy widens, Nature Biotech, Vol 18, March 2000, p
    254 & Gene Research Moves Towards Secrecy, By D. Nelson & R. Weiss, Washington
    Post, Nov 3,199 p A1 & Gene therapy safety issues come to fore, Jeffrey L Fox (1999)
    Nature Biotechnology Vol 17, p 1153 http://www.i-sis.org.uk/gene_therapy.php


	

Open Consultations

Weer twee nieuwe toekomstige toelatingen van gentechmais tot de EU markt (geen teelt alleen voer en voedsel). Je kunt in je eigen taal reageren. Kies een vak en schrijf dat je het niet op je bord wilt hebben!

Public consultations on GM food & feed authorisation applications | Food Safety (europa.eu)Maize Bt 11Scientific opinion on assessment of genetically modified maize Bt11 for renewal authorisation under Regulation (EC) No 1829/2003 (application EFSA-GMO-RX-016)EFSA opinion: 13 January 2021Deadline: 13 February 2021Submit comments
Maize 1507 x MON 810 x MIR162 x NK603Scientific opinion on application for authorisation of genetically modified 1507 x MON 810 x MIR162 x NK603 and subcombinations for food and feed uses submitted under Regulation (EC) No 1829/2003 by by Pioneer Hi-Bred International (EFSA-GMO-NL-2015-127)EFSA opinion: 13 January 2021Deadline: 13 February 2021Submit comments
BRON: EU

Bron EU